Menlo Therapeutics (“MNLO”) I.P.O. Losses

In January 2018, Menlo Therapeutics went public issuing over 8,000,000 shares of common stock at a public offering price of $17.00 raising over 125 million dollars.  NASDAQ lists Menlo’s stock under the ticker symbol “MNLO.”

Jefferies LLC, Piper Jaffray & Co. and Guggenheim Securities served as the lead underwriters.  Menlo’s stock price, MNLO, initially skyrocketed.  However, the stock recently plummeted after poor test results costing investors millions of dollars.

Contact Our Firm if You’ve Invested in Menlo Therapeutics (“MNLO”)

If you invested in Menlo Therapeutics and believe you have lost money due to misrepresentations, you may be able to file a claim to recover your losses. For a free evaluation of your potential case by a securities attorney, please contact Silver Law Group.

Silver Law Group is a nationally-recognized securities law firm headquartered in South Florida representing investors worldwide with their claims for losses due to securities and investment fraud.  The firm has successfully recovered multi-million dollar awards for its clients through securities arbitration and the courts.  To contact Scott L. Silver to discuss your legal matter, call toll-free (800) 975-4345 or e-mail him at SSilver@silverlaw.com.